Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CNC
CNC logo

CNC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
36.670
Open
36.310
VWAP
36.06
Vol
10.27M
Mkt Cap
17.63B
Low
35.660
Amount
370.47M
EV/EBITDA(TTM)
15.21
Total Shares
491.77M
EV
15.08B
EV/OCF(TTM)
2.96
P/S(TTM)
0.09
Centene Corporation is a healthcare company. The Company provides fully integrated services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Its segments include Medicaid, Medicare, Commercial and Other. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
Show More

Events Timeline

(ET)
2026-03-10
16:20:00
Major Averages Close Little Changed as Oil Prices Pull Back
select
2026-03-10
12:10:00
Centene Shares Drop 10.8% to $38.66
select
2026-03-10
12:00:00
Major Averages Rise as Oil Prices Retreat Below $100
select
2026-03-10
10:10:00
Centene Shares Drop 12.8% to $37.79
select
2026-02-19 (ET)
2026-02-19
08:50:00
Beyond Meat Borrow Rate Increases to 52.79%
select

News

seekingalpha
9.5
03-10seekingalpha
PinnedCentene Reaffirms 2026 Earnings Guidance at Barclays Conference
  • Earnings Guidance Reaffirmed: At the Barclays 28th Annual Global Healthcare Conference, Centene expects to reaffirm its 2026 GAAP diluted earnings per share guidance of over $1.98 and adjusted diluted EPS of over $3.00, demonstrating the company's confidence in its future performance.
  • Market Expectations Align: The company's earnings forecast aligns with market analysts' estimates, indicating Centene's stability and ongoing profitability in the healthcare insurance market, which may bolster investor confidence.
  • Margin Improvement: Centene's aggressive repricing and cost-cutting measures have enhanced its margin of safety, indicating effective strategies to improve financial health, which could positively impact its stock price.
  • Industry Dynamics Under Scrutiny: Centene, along with CVS Health and Elevance, has received subpoenas from a House panel, reflecting potential regulatory changes that could affect the company's operations and market positioning.
Newsfilter
8.5
03-10Newsfilter
PinnedTexas Welcomes 14th Foster Care Center of Excellence
  • Foster Center Expansion: Superior HealthPlan has officially designated Cute Pediatrics as the 14th Foster Care Center of Excellence in Texas, marking the first recognition in the Rio Grande Valley and enhancing healthcare quality for foster children in the region.
  • Healthcare Commitment: Cute Pediatrics focuses on providing comprehensive medical services for children from newborn to 21 years, particularly supporting high-risk newborns, ensuring every child’s long-term health and emotional well-being.
  • Quality Standards Enhancement: To achieve this designation, Cute Pediatrics must meet over 30 criteria, including quality improvement initiatives and staff requirements, which not only elevate service quality but also strengthen Superior HealthPlan's leadership position in foster care healthcare.
  • Community Contribution: Since 2020, Superior HealthPlan has contributed $12.3 million in grants and sponsorships to low-income communities, demonstrating its commitment to all 254 Texas counties and further solidifying its status as a leading managed care organization.
seekingalpha
2.0
03-10seekingalpha
Centene Shares Drop 11% After CEO Warns of ACA Headwinds
  • Significant Stock Decline: Centene (CNC) shares plummeted approximately 11% on Tuesday after CEO Sarah London warned at the Barclays Healthcare Conference about persistent headwinds in the Affordable Care Act marketplace operations, which could undermine investor confidence and affect the company's financing capabilities in the short term.
  • Strong Ratings Persist: Despite the stock drop, Seeking Alpha's Quant Ratings still ranks Centene as the top U.S. managed health care stock with a score of 4.31, indicating its relative strength in the market and being the only company to receive a 'Buy' rating, reflecting market recognition of its long-term potential.
  • Competitor Performance: Following Centene, Alignment Healthcare (ALHC) and UnitedHealth Group (UNH) scored 3.32 and 3.28 respectively, indicating relatively lower market confidence in these competitors, which may impact their future market share.
  • Market Environment Challenges: With the Trump administration planning to withhold $259 million in Medicaid payments to Minnesota, the external challenges faced by Centene could intensify, further affecting its operational performance and profitability in the ACA market.
Barron's
4.5
03-10Barron's
U.S. Markets Closed with Mixed Results on Tuesday, Driven by BridgeBio Pharma's Gains and Centene's Declines
  • U.S. Stock Market Performance: U.S. stock indexes closed mixed on Tuesday, with overall performance remaining flat.
  • Index Movements: The Dow Jones Industrial Average dropped by 0.07%, while the S&P 500 fell by 0.21%.
NASDAQ.COM
8.0
03-10NASDAQ.COM
Bio-Techne and UnitedHealth Options Trading Activity Surges
  • Bio-Techne Options Volume: Bio-Techne Corp (Ticker: TECH) has seen an options trading volume of 15,116 contracts today, equating to approximately 1.5 million shares, which represents a significant 62.4% of its average daily trading volume over the past month of 2.4 million shares.
  • High Volume Contracts: Notably, the $60 strike call option for TECH has recorded a high volume of 5,055 contracts traded today, representing around 505,500 underlying shares, indicating strong market interest at this price level.
  • UnitedHealth Options Activity: UnitedHealth Group Inc (Ticker: UNH) has reported an options trading volume of 39,170 contracts today, translating to approximately 3.9 million shares, which is about 47.5% of its average daily trading volume over the past month of 8.3 million shares, reflecting investor focus on its future performance.
  • Key Contract Insights: The $300 strike call option for UNH has seen a trading volume of 2,172 contracts today, representing approximately 217,200 shares, suggesting bullish expectations in the market, potentially linked to anticipated future earnings performance.
Benzinga
9.5
03-10Benzinga
Centene Stock Declines Amid Membership Losses
  • Stock Decline: Centene Corp (NYSE:CNC) shares fell 13.18% to $37.61 on Tuesday, reflecting a 35% drop over the past year, indicating market concerns regarding its future performance.
  • Earnings Guidance Reaffirmed: Despite the pressures, Centene reaffirmed its 2026 earnings guidance of over $1.98 per share and adjusted earnings exceeding $3 per share, demonstrating the company's confidence in its future profitability.
  • Membership Loss Warning: At the Barclays Global Healthcare Conference, Centene warned of lower membership in some Affordable Care Act (ACA) plans, with attrition expected between the high teens and mid-30s, as noted by CEO Sarah London, who indicated they might exceed this range.
  • Increased Utilization Rates: Centene reported a decline in total membership from 28.60 million to 27.63 million for 2025, primarily due to a drop in Medicaid members from 13.00 million to 12.52 million, while higher utilization patterns were noted in specialty pharmacy within the silver tier, indicating shifts in market demand.
Wall Street analysts forecast CNC stock price to rise
15 Analyst Rating
Wall Street analysts forecast CNC stock price to rise
5 Buy
8 Hold
2 Sell
Hold
Current: 0.000
sliders
Low
32.00
Averages
43.07
High
59.00
Current: 0.000
sliders
Low
32.00
Averages
43.07
High
59.00
Mizuho
Neutral
downgrade
$47 -> $41
AI Analysis
2026-03-11
New
Reason
Mizuho
Price Target
$47 -> $41
AI Analysis
2026-03-11
New
downgrade
Neutral
Reason
Mizuho lowered the firm's price target on Centene to $41 from $47 and keeps a Neutral rating on the shares. The firm updated the company's model post the Q4 report. Centene shares were down 14% following the company's comments at a competitor's conference yesterday, the analyst tells investors in a research note. Mizuho cites a more conservative valuation multiple pending greater clarity on the potential risk shifts if health insurance exchange dis-enrollment is worse than expectations for the target cut.
Morgan Stanley
Equal Weight
maintain
$38 -> $45
2026-03-04
Reason
Morgan Stanley
Price Target
$38 -> $45
2026-03-04
maintain
Equal Weight
Reason
Morgan Stanley raised the firm's price target on Centene (CNC) to $45 from $38 and keeps an Equal Weight rating on the shares. Q4 results were "challenged, but relatively cleaner" than peer Molina Healthcare (MOH), the analyst tells investors. Centene expects stable Medicaid margins in 2026 driven by a trend similar to levels in 2025, which the firm calls "more prudent."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CNC
Unlock Now

Valuation Metrics

The current forward P/E ratio for Centene Corp (CNC.N) is 17.95, compared to its 5-year average forward P/E of 12.23. For a more detailed relative valuation and DCF analysis to assess Centene Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
12.23
Current PE
17.95
Overvalued PE
14.98
Undervalued PE
9.48

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.07
Current EV/EBITDA
16.41
Overvalued EV/EBITDA
12.76
Undervalued EV/EBITDA
7.38

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.26
Current PS
0.11
Overvalued PS
0.33
Undervalued PS
0.18

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Market Movers
Intellectia · 392 candidates
Region: USPrice: $1.00 - $500.00Price Change Pct: $-100.00 - $-3.00Relative Vol: >= 1.20List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
TURB logo
TURB
Turbo Energy SA
55.64M
RAIL logo
RAIL
FreightCar America Inc
241.92M
DTCK logo
DTCK
Davis Commodities Ltd
3.41M
SMX logo
SMX
SMX (Security Matters) PLC
65.03M
BNTX logo
BNTX
Biontech SE
25.64B
BHAT logo
BHAT
Blue Hat Interactive Entertainment Technology
5.33M
stocks that are steadily rising
Intellectia · 40 candidates
Rsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Quarter Price Change Pct: $20.00 - $80.00Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
DG logo
DG
Dollar General Corp
31.28B
CMI logo
CMI
Cummins Inc
80.48B
AKAM logo
AKAM
Akamai Technologies Inc
14.98B
EXPD logo
EXPD
Expeditors International of Washington Inc
21.73B
MRK logo
MRK
Merck & Co Inc
270.47B
SLB logo
SLB
Slb NV
73.52B
whats the next best swing trade
Intellectia · 70 candidates
Rsi Category: moderateMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Month Price Change Pct: $8.00 - $25.00Is Index Component: GSPC, NDXMonthly Average Dollar Volume: >= 2,000,000
Ticker
Name
Market Cap$
top bottom
CMI logo
CMI
Cummins Inc
78.93B
LRCX logo
LRCX
Lam Research Corp
273.74B
DE logo
DE
Deere & Co
139.45B
PPG logo
PPG
PPG Industries Inc
25.20B
DXCM logo
DXCM
Dexcom Inc
28.42B
MHK logo
MHK
Mohawk Industries Inc
7.46B
short term investment best picks
Intellectia · 26 candidates
Market Cap: >= 15.00BPrice: $10.00 - $150.00Month Price Change Pct: $8.00 - $30.00One Week Rise Prob: >= 70Monthly Average Dollar Volume: >= 1,500,000
Ticker
Name
Market Cap$
top bottom
PBR logo
PBR
Petroleo Brasileiro SA Petrobras
92.03B
PPG logo
PPG
PPG Industries Inc
25.20B
DXCM logo
DXCM
Dexcom Inc
28.42B
CNC logo
CNC
Centene Corp
22.65B
PKX logo
PKX
Posco Holdings Inc
19.18B
CNQ logo
CNQ
Canadian Natural Resources Ltd
75.28B
Can you tell me what to buy and why
Intellectia · 49 candidates
Price: $5.00 - $50.00Rsi Category: moderateList Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20Is Index Component: GSPC, NDXMonthly Average Dollar Volume: >= 25,000,000
Ticker
Name
Market Cap$
top bottom
PFE logo
PFE
Pfizer Inc
147.20B
SMCI logo
SMCI
Super Micro Computer Inc
19.25B
CMCSA logo
CMCSA
Comcast Corp
105.27B
F logo
F
Ford Motor Co
54.87B
KVUE logo
KVUE
Kenvue Inc
33.30B
CMG logo
CMG
Chipotle Mexican Grill Inc
53.84B

Whales Holding CNC

M
Maple Rock Capital Partners Inc.
Holding
CNC
+28.07%
3M Return
K
Kopernik Global Investors, LLC
Holding
CNC
+12.91%
3M Return
A
Agnico Eagle Mines Limited
Holding
CNC
+7.79%
3M Return
A
Arax Advisory Partners, LLC
Holding
CNC
+5.46%
3M Return
T
Thompson, Siegel & Walmsley LLC
Holding
CNC
+4.87%
3M Return
A
ARGA Investment Management, LLC
Holding
CNC
+4.09%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Centene Corp (CNC) stock price today?

The current price of CNC is 35.86 USD — it has decreased -1.48

What is Centene Corp (CNC)'s business?

Centene Corporation is a healthcare company. The Company provides fully integrated services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Its segments include Medicaid, Medicare, Commercial and Other. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.

What is the price predicton of CNC Stock?

Wall Street analysts forecast CNC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNC is43.07 USD with a low forecast of 32.00 USD and a high forecast of 59.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Centene Corp (CNC)'s revenue for the last quarter?

Centene Corp revenue for the last quarter amounts to 49.73B USD, increased 21.86

What is Centene Corp (CNC)'s earnings per share (EPS) for the last quarter?

Centene Corp. EPS for the last quarter amounts to -2.24 USD, decreased -500.00

How many employees does Centene Corp (CNC). have?

Centene Corp (CNC) has 61100 emplpoyees as of March 12 2026.

What is Centene Corp (CNC) market cap?

Today CNC has the market capitalization of 17.63B USD.